Navigation Links
New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting

promising pain response rate of 69% (based on a decrease of at least two points on a 10 point scale.)

Society of Nuclear Medicine Abstracts

Cytogen also reported today the presentation of a number of abstracts related to investigator-sponsored studies with QUADRAMET or Cytogen's monoclonal antibody-based molecular imaging agent for prostate cancer, PROSTASCINT(R) (capromab pendetide), at the 54th Annual Meeting of the Society of Nuclear Medicine taking place through June 6, 2007 in Washington, DC. The abstract titles and publication numbers are as follows:

"Combination of radionuclide therapy using Sm-153-Lexidronam and chemotherapy in patients with bone metastases of hormone refractory prostate cancer (HRPC): First results", by Nestle, et al. Saarland University Medical Center, Homburg/Saar, Germany (Abstract No. 127, Sunday, June 3, 2007, 5:03 PM)

"Radiation safety of outpatient therapy in patients receiving high-dose Sm-153 EDTMP treatment: A prospective study", by Bartosh et al., The University of Texas MD Anderson Cancer Center, Houston, Texas (Abstract No. 2027, Monday June 4, 2007, 1:42 PM)

"Comparison of animal biodistribution of EDTMP labeled with various beta emitting lanthanides", by Sohaib, et al., Pakistan Institute of Nuclear Sciences and Technology (PINSTECH), Islamabad, Pakistan (Abstract No. 461, Tuesday June 5, 2007, 3:18 PM)

"ProstaScint imaging - Reviewing the fundamentals", by Sureshbabu, et al., Excel Diagnostics Imaging Clinics, Houston, Texas (Abstract No. 2103, Monday June 4, 2007, 2:30 PM)

"Use of SPECT/CT in tumor localization: SPECT/CT versus planar and SPECT imaging in tumor localization" by Levi, et al. Florida Hospital College of Health Sciences, Orlando, Florida (Abstract No. 2228, Monday, June 4, 2007, 8:50 AM)

"Added value of SPECT-CT in patients explored by 111In-Capromab Pendetide (ProstaScint)", by Belhocine, et al. (Abstract No. 653, Wednesday June 6, 2007, 9:45 AM)


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Preclinical Data on Cytogens Technology to be Reported at the AACR Annual Meeting
2. New Clinical Data for Cytogens Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings
3. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
4. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
5. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
6. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
7. VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
8. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
9. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
10. Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
11. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Data for Cytogen QUADRAMET Reported Annual ASCO Meeting
(Date:11/6/2009)... 6 NexBio Inc., in collaboration w...and Prevention (CDC), St. Louis University, and th...lication of two articles in the peer-reviewed jour... that DAS181 (Fludase ® ) may play a potentia...n of the Pandemic Influenza A(H1N1) and drug-resis...
(Date:11/6/2009)...mber 6 , - Trial Will Com...the,Treatment of Multi-Resistant Staphylococcus Au...ality pharmaceutical company focused on the discov...to overcome the significant global,problem of micr...vanced oral,antibacterial NXL103 (flopristin/linop...
(Date:11/5/2009)... Calif., Nov. 5 Transcep...lty pharmaceutical company focused on the developm...that address important therapeutic needs in the fi...a webcast and teleconference with management to di...sday, November 12, 2009, at 5:00 p.m. Eastern Stan...
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2New Website www loseadresssize com Launches 53709 1New Website www loseadresssize com Launches 53709 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 1Pharmacyclics Inc Rights Offering Oversubscribed 13381 2Pharmacyclics Inc Rights Offering Oversubscribed 13381 3Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 1Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 2
...ement Studied in Largest-Ever IVF Trial,in US, RAN... Results of,four studies evaluating Ferring Pharma...inal insert in development for luteal phase,suppor...tion and,the early stages of pregnancy) in assiste...t the 55th Annual Meeting of the,Pacific Coast Rep...
...NESS WIRE)--Apr 18, 2007 - Avanir,Pharmaceuticals ...sults from the company,s Phase III clinical trial ...xtromethorphan,hydrobromide/quinidine sulfate ("DM...iabetic neuropathic pain., The primary endpoint of...r the Pain Rating Scale as defined in the Special,...
Other Medicine Technology:Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 4Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 6
(Date:11/8/2009)...rying of biopharmaceuticals to be available at the..., Toronto, ON (PRWEB) Nove...of Therapure Biopharma Inc. today announced that t...e pharmaceutical grade freeze dryer and expects to...on) available for contract manufacturing of biopha...
(Date:11/8/2009)...the battle is won," said Dr. Charmaine Yoest. ,...n a vote of 240-194, the Stupak-Ellsworth-Pitts-Ka...it abortion mandates and funding in HR 3962 passed...fe Action President and CEO Dr. Charmaine Yoest sa...r the pro-life Americans across this country who h...
(Date:11/8/2009)...H.R. 3961 to Secure the Stability of Medicare ,...ement Attributable to: J. James Rohack, M.D., Pres... http://www.newscom.com/cgi-bin/prnh/20081209/AMA...ouse health reform bill, which will help improve t...alls for swift passage of H.R. 3961 to secure the ...
(Date:11/8/2009)...of Health Care Reform Bill ,, Critical legisl...for all Americans ,, BALTIMORE, Nov. 7 /PRNews...States House of Representatives passed critical he... Medicare for seniors and end discrimination by in...s out of affordable health coverage. ,, The Aff...
(Date:11/7/2009)...-USNewswire/ -- The American Medical Association (...r Citizenship and Community Service to Manus C. Kr...e award recognizes physicians who have gone above ... an outstanding public service contribution to the...oday during the opening session of the 2009 Interi...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
... General Hospital Lawsuit , , VANCOUVER, May 21 /... TSX: QLT) announced that on May 21, 2009, the Dis...sued an oral ruling on QLT,s Motion to Dismiss all...l decision, the District Court dismissed all of th...
... Action to Improve Delivery of PMTCT , , GENEVA, ...headquarters in Geneva, members of the Internation...S-Free World met with the leaders and approximatel...on and Women,s Health, which identifies the failu...
... care practitioner, Trina Hammack knew the statist...r, she knew her prognosis was bleak. Fortunately,...ring effective new treatments for ovarian cancer. ...native treatments. , , Hammack owns Cornerstone W...
...ticals, Inc. (OTC: IMMP) announced today that the ...on the Pink OTC Markets quotation system on or abo...MMP". , , As announced previously, on March 27, 2...e Corporate Compliance Department of NYSE Regulati...
...rses Back To Job Market , , BERKELEY, Calif., May...hospitals -- a result of the economic recession --...eloras Jones, RN, MS, executive director of the Ca...actor in the job market for registered nurses (RNs...
...tering, which experts prefer , , THURSDAY,...ne while people are asleep, not only frees up time...r health as well, a new study suggests. , Although... done while a person sleeps. , "The concept is sim...
Other Medicine News:Health News:QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court 2Health News:QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court 3Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 2Health News:AIDS Treatment Activists Push UNAIDS and WHO to Meet Commitments to Reduce HIV in Women and Newborns 3Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:Immtech to be Listed on OTC Market 2Health News:Hard Times for Nursing Hires Doesn't Signal End to Shortage According to California Institute for Nursing & Health Care 2Health News:Sleeping Through Dialysis May Be the Way to Go 2Health News:Sleeping Through Dialysis May Be the Way to Go 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: